Abstract:
Novel benzodiazepine compounds of formula (1) which exhibit agonistic activity for CCK-A receptors enabling them to modulate the hormones gastrin and cholecystokinin (CCK) in mammals for use in medicine as anorectic agents in the regulation of appetite, the treatment of obesity and the maintenance of weight loss.
Abstract:
The present invention comprises a method for measuring the amount, i.e., mass, of a volatile liquid which comprises passing the mass (18) over a heat loss measuring device (6, 8), calculating the amount of heat loss accompanying the vaporization of the mass and correlating the heat loss to measurement of heat loss of known liquid aerosol mass made with the same device. The method is especially useful in assuring uniform metered doses among multiple aerosol containers (12).
Abstract:
Peptide nucleic acids oligomers of formula (I) wherein n is 1 or more, particularly about 5-20 and B is independently one of the 4 nucleoside bases or their equivalents, Q and J are end groups useful in anti-sense oligomers and their use in affecting genetic material, e.g. as triplex or antisense in the treatment of disease.
Abstract:
The present invention relates to certain substituted tetracyclic fused quinoline derivatives of formula (I), wherein R1 is hydrogen, hydroxy, fluoro, chloro, bromo, iodo, methoxy or amino; R2 is hydrogen, hydroxy, methoxy or amino; R3 is hydrogen, hydroxy, methoxy, methoxymethoxy, amino, -OCONH¿2?, [2(5H)-3,4-dihydro-3-oxyfuranone], 2-hydroxyethoxy, 2-aminoethoxy, 3-hydroxypropoxy or 3-aminopropoxy; or taken together with R?2 or R4¿, methylenedioxy or ethylenedioxy; R4 is hydrogen, hydroxy or amino; Z is -CH¿2?-, -O- or -NH-; and a) X?1¿ is hydrogen; X2 is hydrogen, hydroxy, fluoro, chloro, bromo, iodo or methoxy; and X3 is hydrogen or hydroxy; or b) X2 taken together with X3 is methylenedioxy or etylenedioxy, and X1 is hydrogen or a pharmaceutically acceptable salt thereof provided that: i) at least one of R1 through R4 is other than hydrogen; ii) when R1 is methoxy, R2 is hydroxy or methoxy, R3 is hydrogen or methoxy and R4 is hydrogen; iii) when R2 is hydroxy, methoxy or amino, R3 is hydrogen, hydroxy or methoxy, and R4 is hydrogen; iv) when R4 is hydroxy or amino, R?1 and R3¿ are hydrogen and R2 is hydroxy or amino; and v) when R1 is fluoro, chloro, iodo or amino, R2 is hydrogen, hydroxy or methoxy, R3 is hydrogen, hydroxy or methoxy and R4 is hydrogen and the use of these compounds as topoisomerase inhibitors and antitumor agents.
Abstract:
This invention relates to new process for preparing certain optically active purine substituted cyclopentene derivatives and novel intermediates used in this process. In particular, the invention concerns the synthesis of the 1R-cis isomer of carbovir, (1R-cis)-amino-1,9-dihydro-9-[4-(hydroxymethyl)-2-cyclopenten-1-yl]-6H-purin-6-one, an antiviral agent, and certain intermediates.
Abstract:
This invention relates to a new process for preparing certain optically active cyclopentene derivatives and novel intermediates used in this process. In particular, the invention concerns the synthesis of the 1'R-cis isomer of carbovir, (1'R-cis)-2-amino-1,9-dihydro-9[4-(hydroxymethyl)-2-cyclopenten-1-yl]- 6H-purin-6-one, an antiviral agent.
Abstract:
The present invention comprises a method for measuring the amount, i.e., mass, of a volatile liquid which comprises passing the mass (18) over a heat loss measuring device (6, 8), calculating the amount of heat loss accompanying the vaporization of the mass and correlating the heat loss to measurement of heat loss of known liquid aerosol mass made with the same device. The method is especially useful in assuring uniform metered doses among multiple aerosol containers (12).
Abstract:
A sequential dosing medicament for topical treatment of fungal infections comprising a first pharmaceutical composition having an antifungal agent and an antiinflammatory agent, e.g. a steroid, a second separate pharmaceutical composition having only an antifungal agent as the active ingredient. Also, a method for such sequential dosing, particularly using oxiconazole as the antifungal agent and fluticasone as the steroid.
Abstract:
This invention relates to new process for preparing certain optically active purine substituted cyclopentene derivatives and novel intermediates used in this process. In particular, the invention concerns the synthesis of the 1R-cis isomer of carbovir, (1R-cis)-amino-1,9-dihydro-9-[4-(hydroxymethyl)-2-cyclopenten-1-yl]-6H-purin-6-one, an antiviral agent, and certain intermediates.
Abstract:
A pneumatic apparatus 10 for withdrawing and recycling goods from defective blister packages on a blister packaging machine comprising a housing 12 which is positioned on the blister packaging machine between the detection station and the sealing station and having a plurality of transversely spaced-apart open chambers 12B in the bottom thereof. A plurality of air valves 14 are connected to a high air pressure source and to the blister package machine detection station, and each air valve 14 corresponds to a respective chamber 12B in the bottom of the housing 12. A plurality of air venturi nozzles 20 are provided wherein each air venturi nozzle 20 is fluidly connected at its air pressure input end 20A to a corresponding air valve 14 and chamber 12B. Each nozzle 20 comprises a goods transportation conduit connected to its air exhaust exhaust end 20B so the air venturi nozzle 20 will create a partial vacuum in the chamber 12B fluidly connected thereto and a pressurized air flow in the goods transportation conduit at the air exhaust end 20B thereof when the air valve 14 corresponding thereto is opened. Upon receiving a signal from the detection station, the pneumatic goods recycling apparatus will pneumatically withdraw the goods from predetermined portions of a carrier strip from which blister sections will be separated and which each have at least one empty cell therein and then propel the goods back to the blister packaging machine hopper.